MT-II acts as a non-selective agonist at melanocortin receptors (MC1R, MC3R, MC4R, MC5R), with its most extensively studied effect being the stimulation of melanogenesis the biological process by which melanin pigment is produced in skin and hair follicles
As of March 2025, 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs
Current studies suggest retatrutide may provide greater average weight loss than semaglutide, but the best treatment approach depends on each individuals goals, health profile, and response to therapy
Do not take tub baths until you talk with your doctor at your first appointment after your surgery
With compounded drugs, its harder to be sure
When its compounded by a third party, they can skip many of those quality assurance stop signs. According to the FDA, compounding pharmacies are allowed to make copies of commercially available drugs when they are on the agencys drug shortages list